The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide “around-the-clock” relief to patients with moderate to severe pain.
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide “around-the-clock” relief to patients with moderate to severe pain.
